{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T13:30:00Z","timestamp":1791811800994,"version":"4.3.4"},"reference-count":29,"publisher":"S. Karger AG","issue":"6","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urol Int"],"published-print":{"date-parts":[[2023]]},"abstract":"<jats:p>Introduction: In this study, we aimed to explore using the predictive role of systemic immune inflammation index (SII) for responses of intravesical Bacillus Calmette-Gu\u00e9rin (BCG) therapy in patients with intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC). Methods: From 9 centers, we reviewed the data of patients treated for intermediate- and high-risk NMIBC between 2011 and 2021. All patients enrolled in the study presented with T1 and\/or high-grade tumors on initial TURB had undergone re-TURB within 4\u20136 weeks after initial TURB and had received at least a 6-week course of intravesical BCG induction. SII was calculated with the formula SII = (P \u00d7 N)\/L, where P, N, and L refer to peripheral platelet, neutrophil, and lymphocyte counts, respectively. In patients with intermediate- and high-risk NMIBC, the clinicopathological features and follow-up data were evaluated to compare SII with other systemic inflammation-based prognostic indices. These included the neutrophil-to-lymphocyte ratio (NLR), platelet-to-neutrophil ratio (PNR), and platelet-to-lymphocyte ratio (PLR). Results: A total of 269 patients were enrolled in the study. Median follow-up time was 39 months. Disease recurrence and progression were observed in 71 (26.4%) and 19 (7.1%) patients, respectively. For groups with and without disease recurrence in terms of NLR, PLR, PNR, and SII calculated prior to intravesical BCG treatment, no statistically significant differences were observed (p = 0.470, p = 0.247, p = 0.495, and p = 0.243, respectively). Moreover, there were also no statistically significant differences between the groups with and without disease progression in terms of NLR, PLR, PNR, and SII (p = 0.504, p = 0.165, p = 0.410, and p = 0.242, respectively). SII did not show any statistically significant difference between early (&lt;6 months) and late (\u22656 months) recurrence (p = 0.492) and progression groups (p = 0.216). Conclusion: For patients with intermediate- and high-risk NMIBC, serum SII levels do not present as an appropriate biomarker for the prediction of disease recurrence and progression following intravesical BCG therapy. A possible explanation for the failure of SII to predict BCG response may be found in the impact of Turkey\u2019s nationwide tuberculosis vaccination program. <\/jats:p>","DOI":"10.1159\/000528740","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T22:03:58Z","timestamp":1677017038000},"page":"617-623","source":"Crossref","is-referenced-by-count":10,"title":["Predictive Role of the Systemic Immune Inflammation Index for Intravesical BCG Response in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer"],"prefix":"10.1159","volume":"107","author":[{"given":"Deniz","family":"Bolat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumer","family":"Baltaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6187-1940","authenticated-orcid":false,"given":"Murat","family":"Akgul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre","family":"Karabay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkan","family":"Izol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3715-1761","authenticated-orcid":false,"given":"Guven","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1169-870X","authenticated-orcid":false,"given":"Saadettin","family":"Eskicorapci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayrettin","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levent","family":"Turkeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Members of Bladder Cancer Study Group of Turkish Urooncology Association","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"127","published-online":{"date-parts":[[2023,2,21]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.12.033"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2018.07.032"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/00005392-200001000-00015"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.06.045"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2007.10.006"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2017.10.003"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1590\/S1677-5538.IBJU.2018.0249"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-019-02754-2"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-0348-0837-8_8"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.26355\/eurrev_202102_24834"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-3661"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-019-02325-9"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S259117"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-021-03740-3"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13813"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2013.07.102"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-020-01974-w"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27373"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2021.1991591"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v7.i8.111"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-01590-4"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2021.10.006"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110393"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-018-0055-4"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2021.11.027"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602026"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/cas.12075"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003586"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2017.10.005"}],"container-title":["Urologia Internationalis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/karger.com\/uin\/article-pdf\/107\/6\/617\/3965397\/000528740.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/karger.com\/uin\/article-pdf\/107\/6\/617\/3965397\/000528740.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T15:06:14Z","timestamp":1745420774000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000528740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6,6]]},"published-print":{"date-parts":[[2023,6,13]]}},"URL":"https:\/\/doi.org\/10.1159\/000528740","archive":["Portico"],"relation":{},"ISSN":["0042-1138","1423-0399"],"issn-type":[{"value":"0042-1138","type":"print"},{"value":"1423-0399","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]}}}